This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of antiviral medications. It plays a crucial role in the development of drugs targeting viral infections, particularly those caused by influenza viruses. The adamantane moiety in its structure is significant for its ability to inhibit viral replication by blocking the M2 ion channel, which is essential for the virus's life cycle. Additionally, it is explored in research for potential applications in treating neurodegenerative diseases, such as Parkinson's and Alzheimer's, due to its ability to modulate certain neurotransmitter systems. Its hydrochloride form enhances solubility, making it more suitable for formulation into various drug delivery systems.